Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.15 USD | +7.11% | -4.04% | -48.19% |
15/04 | RBC Lowers Price Target on Nevro to $16 From $18, Keeps Sector Perform Rating | MT |
11/04 | Mizuho Adjusts Price Target on Nevro to $16 From $20, Maintains Neutral Rating | MT |
Business Summary
Number of employees: 1,215
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Medical Devices
100.0
%
| 406 | 100.0 % | 425 | 100.0 % | +4.63% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
86.2
%
| 348 | 85.7 % | 367 | 86.2 % | +5.28% |
International
13.8
%
| 58 | 14.3 % | 59 | 13.8 % | +0.72% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Kevin Thornal
CEO | Chief Executive Officer | 50 | 24/23/24 |
D. Grossman
CHM | Chairman | 63 | 19/19/19 |
Roderick MacLeod
DFI | Director of Finance/CFO | 57 | 15/20/15 |
David Caraway
CTO | Chief Tech/Sci/R&D Officer | 67 | 01/14/01 |
Chief Tech/Sci/R&D Officer | 73 | 20/20/20 | |
Chief Tech/Sci/R&D Officer | 54 | 01/16/01 | |
Geeta Kaveti
CMP | Compliance Officer | - | - |
Kerry Bradley
CTO | Chief Tech/Sci/R&D Officer | - | - |
Michael DeMane
BRD | Director/Board Member | 67 | 17/11/17 |
Angeline McCabe
IRC | Investor Relations Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michael DeMane
BRD | Director/Board Member | 67 | 17/11/17 |
Karen Prange
BRD | Director/Board Member | 60 | 17/19/17 |
D. Grossman
CHM | Chairman | 63 | 19/19/19 |
Director/Board Member | 64 | 19/19/19 | |
Kevin O'Boyle
BRD | Director/Board Member | 68 | 19/19/19 |
Frank Fischer
BRD | Director/Board Member | 82 | 01/12/01 |
Susan Siegel
BRD | Director/Board Member | 63 | 02/20/02 |
Shawn McCormick
BRD | Director/Board Member | 59 | 01/14/01 |
Sridhar Kosaraju
BRD | Director/Board Member | 46 | 31/21/31 |
Kevin Thornal
CEO | Chief Executive Officer | 50 | 24/23/24 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 37,364,308 | 35,498,213 ( 95.01 %) | 682,916 ( 1.828 %) | 95.01 % |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-48.19% | 382M | |
-3.77% | 184B | |
-1.77% | 107B | |
-1.43% | 67.52B | |
+2.06% | 50.06B | |
+9.43% | 45.67B | |
+3.40% | 41B | |
+3.04% | 26.73B | |
+4.64% | 26.47B | |
+15.23% | 25.05B |
- Stock Market
- Equities
- NVRO Stock
- Company Nevro Corp.